Due to these criticisms, the diagnostic utility of NLR in distinguishing Patients with AD from HCs has been questioned, as it may be significantly affected by confounding variables including age, sex, and the apolipoprotein E gene (APOE) allele status [70]. This evidence concerns the gene APOE and Alzheimer disease.